Sepulcre Jorge, Masdeu Joseph C, Palacios Ricardo, Goñi Joaquín, Moreno Beatriz, Tainta Mikel, Bejarano Bartolomé, Villoslada Pablo
Department of Neurology and Neurosurgery of the Clínica Universitaria de Navarra, Pamplona, Spain.
J Neuroimaging. 2008 Jul;18(3):328-31. doi: 10.1111/j.1552-6569.2008.00259.x. Epub 2008 May 8.
Human leukocyte antigen DR2 (HLA-DR2) is a well-established genetic risk factor for multiple sclerosis (MS). However, it is still unknown whether this factor is associated with a specific disease phenotype, and in particular, to a regional distribution of white matter (WM) lesion phenotype on magnetic resonance imaging (MRI). On a voxel-by-voxel basis, we analyzed the T1 and T2 MRI-derived lesion maps of 50 patients with MS in order to determine the possible influence of HLA-DR2 genotype on the lesional MRI pattern at early stages of the disease. HLA-DR2 was present in 15 (30%) patients of our cohort. They displayed similar WM lesion distribution as the subjects without this factor. Thus, lesion distribution in MS seems to be independent of the DR2 genotype.
人类白细胞抗原DR2(HLA - DR2)是多发性硬化症(MS)公认的遗传风险因素。然而,该因素是否与特定疾病表型相关,特别是与磁共振成像(MRI)上白质(WM)病变表型的区域分布相关,仍不清楚。我们逐体素分析了50例MS患者的T1和T2 MRI衍生病变图谱,以确定HLA - DR2基因型在疾病早期对病变MRI模式的可能影响。我们队列中有15名(30%)患者存在HLA - DR2。他们与没有该因素的受试者表现出相似的WM病变分布。因此,MS中的病变分布似乎与DR2基因型无关。